Find a Clinical Trial

Scars (CTP002-1): A study of the ReCell® Autologous Cell Harvesting Device for healing of dermabraded scars: a feasibility study (1_PRO00000098)

Ankle or Foot Injuries: The Effect of Triage-Based Application of the Ottawa Ankle and Foot Rules (OAR/OFR) on the Number of Radiographs Ordered: A Pilot Study (Investigator-initiated study) (1_PRO00000185)

Copperhead snake bites/ A Randomized, Double-Blind, Placebo-Controlled Study comparing CroFab® versus Placebo with Rescue Treatment for Copperhead Snake Envenomation (1_PRO00001099)

Deep Vein Thrombosis: STA® -Liatest® D-Di  Exclusion of Venous Thromboembolism (VTE) (1_PRO00001084)

Smoking Cessation/ Recruitment Feasibility Study for Reducing Postpartum Smoking among Low-income and Hispanic Women (1_PRO00000417)

ALTE03N1: Key Adverse Events Following Childhood Cancer

 

Randomized, Double-Blind Phase III Study of Pazopanib vs. Placebo in Patients with Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease Following Metastasectomy

COG ALTE07C1: Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children with Cancer

 

ALTEO5N1: UMBRELLA LONG-TERM FOLLOW-UP PROTOCOL

 

Lung Tumors in Children: The international pleuropulmonary blastoma (PPB) registry

Urinary Tract Cancer (CALGB-90601): A randomized double-blinded phase III study comparing gemcitabine, cisplatin, and bevacizumab to gemcitabine, cisplatin, and placebo in patients with advanced transitional cell carcinoma, NCI supplies agent(s)

ABTR01B1: Children's Oncology Group protocol for collecting and banking pediatric research specimens including rare pediatric tumors

 

Wilms Tumor (COG #AREN0534): Treatment for Patients with Bilateral, Multicentric, or Bilaterally-Predisposed Unilateral Wilms Tumor: A Group-wide Phase III Study (1_PRO00000569 - CIRB)

Cancer with Bone Metastases (SWOG S0702): A prospective observational multicenter cohort study to assess the incidence of osteonecrosis of the jaw (ONJ) in cancer patients with bone metastases starting zoledronic

Endometrial Cancer (GOG #0258): A randomized phase III trial of cisplatin and tumor volume directed irradiation followed by carboplatin and paclitaxel versus carboplatin and paclitaxel for optimally debulked, advanced endometrial

Melanoma (ECOG #E1609): A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon a-2b for Resected High-Risk Melanoma (2_PRO00000797 - CIRB)

Gynecologic Tissue: The Lehigh Valley Health Network Gynecologic Oncology Tissue Project (1_PRO00000035)

Previously Untreated unresectable or metastatic melanoma: BMS 209-067: A Phase 3, Randomized, Double-Blind Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab Versus Ipilimumab Monotherapy in Subjects with Previously Untreated

Advanced Non-small Cell Lung Cancer (SWOG-S0819): A randomized, phase III study comparing carboplatin/paclitaxel or arboplatin/paclitaxel/bevacizumab with or without concurrent cetuximab in patients with advanced non-small cell lung cancer (NSCLC) (2_PRO00000696

Lung Cancer (E6508): A phase II study of L-BLP25 and bevacizumab in unresectable stage IIIA and IIIB non-squamous non-small cell lung cancer after definitive chemoradiation (2_PRO00000270)

Non-Small Cell Lung Cancer/ CLDK378A2402: An open-label, multi-center, Expanded Treatment Protocol (ETP) of oral LDK378 in adult patients with non-small cell lung cancer (NSCLC) characterized by ALK positivity (1_PRO00001585)

Leukemia (ECOG E3903): Ancillary laboratory protocol for the collection of diagnostic material on patients considered for ECOG treatment trials for leukemia or related hematologic disorders (2_PRO00000429)

HIV (A4001067/1322): An international, multicenter, prospective observational study of the safety of Maraviroc used with optimized background therapy in treatment-experienced HIV-1 infected patients (1_PRO00000036)

HIV in Women (GS-US-236-0128): A randomized, double-blind phase 3B study to evaluate the safety and efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus emtricitabine/tenofovir disoproxil fumarate in HIV-1 infected

Leukemia (CA 180-330): Studying interventions for managing patients with chronic myeloid leukemia in chronic phase: the 5-year prospective cohort study (SIMPLICITY) (2_PRO00000118)